Retour
Fourchette du Jour
14,40 €
14,41 €
Fourchette 52 Semaines
5,51 €
14,43 €
Volume
3 099 217
Moyenne 50J / 200J
14,33 €
/
9,82 €
Clôture Précédente
14,42 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -166,9 | 0,3 |
| P/B | 16,5 | 2,9 |
| ROE % | -11,6 | 3,7 |
| Net Margin % | -4,3 | 3,8 |
| Rev Growth 5Y % | 20,0 | 10,0 |
| D/E | 1,8 | 0,2 |
Objectif de Cours des Analystes
Hold
14,50 €
+0.6%
P/E Prévisionnel
47,6
BPA Prévisionnel
0,30 €
Croissance BPA (est.)
+0,0%
CA Est.
750 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,67 €
1,62 € – 1,72 €
|
1,5 B | 2 |
| FY2029 |
1,36 €
1,32 € – 1,40 €
|
1,3 B | 2 |
| FY2028 |
0,91 €
0,75 € – 1,05 €
|
1,1 B | 4 |
Points Clés
Revenue grew 20,03% annually over 5 years — strong growth
Generating 29,85M in free cash flow
Capital efficient — spends only 0,52% of revenue on capex
ROIC of 3,41% — low return on invested capital
Interest coverage of 0,75× — tight debt servicing
Croissance
Revenue Growth (5Y)
20,03%
Revenue (1Y)20,05%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-11,58%
ROIC3,41%
Net Margin-4,27%
Op. Margin5,44%
Sécurité
Debt / Equity
1,76
Current Ratio2,84
Interest Coverage0,75
Valorisation
P/E Ratio
-166,90
P/B Ratio16,50
EV/EBITDA138,99
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 20,05% | Revenue Growth (3Y) | 26,02% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 20,03% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 634,21M | Net Income (TTM) | -27,11M |
| ROE | -11,58% | ROA | -2,85% |
| Gross Margin | 87,32% | Operating Margin | 5,44% |
| Net Margin | -4,27% | Free Cash Flow (TTM) | 29,85M |
| ROIC | 3,41% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,76 | Current Ratio | 2,84 |
| Interest Coverage | 0,75 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -166,90 | P/B Ratio | 16,50 |
| P/S Ratio | 7,13 | PEG Ratio | 3,17 |
| EV/EBITDA | 138,99 | Dividend Yield | 0,00% |
| Market Cap | 4,52B | Enterprise Value | 4,79B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 634,21M | 528,30M | 399,36M | 329,23M | 305,51M |
| Net Income | -27,11M | -56,11M | -151,58M | -236,57M | -250,46M |
| EPS (Diluted) | -0,09 | -0,18 | -0,51 | -0,82 | -0,92 |
| Gross Profit | 553,82M | 475,35M | 362,03M | 290,63M | 271,05M |
| Operating Income | 34,49M | 24,88M | -77,21M | -212,12M | -206,43M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 949,87M | 785,03M | 777,88M | 724,17M | 905,14M |
| Total Liabilities | 675,63M | 590,99M | 617,71M | 601,12M | 597,77M |
| Shareholders' Equity | 274,24M | 194,05M | 160,17M | 123,05M | 307,37M |
| Total Debt | 483,33M | 443,64M | 445,06M | 452,12M | 440,13M |
| Cash & Equivalents | 214,01M | 213,75M | 246,99M | 148,81M | 245,20M |
| Current Assets | 676,17M | 504,74M | 483,06M | 423,82M | 596,83M |
| Current Liabilities | 237,83M | 148,70M | 167,69M | 139,02M | 145,98M |